Skip to content
10-K

Annual Report

GB SCIENCES INC

0001437749-24-028160

← back to feed
Filed
Aug 30, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Aug 30, 2024 407.07M sh
Operating Cash Flow FY 2024 · Mar 31, 2024 −$975.7K
Operating Cash Flow FY 2024 · Mar 31, 2023 −$1.53M
Short Term Investments FY 2024 · Mar 31, 2024 $0
Cash And Equivalents FY 2024 · Mar 31, 2024 $11.99K
Cash And Equivalents FY 2024 · Mar 31, 2023 $109.91K
Stockholders Equity FY 2024 · Mar 31, 2024 −$5.31M
Stockholders Equity FY 2024 · Mar 31, 2023 −$4.41M
Current Liabilities FY 2024 · Mar 31, 2024 $5.1M
Current Liabilities FY 2024 · Mar 31, 2023 $4.76M
Total Liabilities FY 2024 · Mar 31, 2024 $5.42M
Total Liabilities FY 2024 · Mar 31, 2023 $4.76M
Current Assets FY 2024 · Mar 31, 2024 $103.44K
Current Assets FY 2024 · Mar 31, 2023 $309.5K
Total Assets FY 2024 · Mar 31, 2024 $103.44K
Total Assets FY 2024 · Mar 31, 2023 $352.32K
Eps Basic FY 2024 · Mar 31, 2024 $0.00
Eps Basic FY 2024 · Mar 31, 2023 −$0.01
Rd Expense FY 2024 · Mar 31, 2024 $261.55K
Rd Expense FY 2024 · Mar 31, 2023 $490.29K
Net Income FY 2024 · Mar 31, 2024 −$1.36M
Net Income FY 2024 · Mar 31, 2023 −$4.13M
Operating Income FY 2024 · Mar 31, 2024 −$1.42M
Operating Income FY 2024 · Mar 31, 2023 −$1.67M
Gross Profit FY 2024 · Mar 31, 2024 $0
Gross Profit FY 2024 · Mar 31, 2023 $0
Cost Of Revenue FY 2024 · Mar 31, 2024 $0
Cost Of Revenue FY 2024 · Mar 31, 2023 $0
Revenue FY 2024 · Mar 31, 2024 $0
Revenue FY 2024 · Mar 31, 2023 $0